Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chest discomfort, Expired product administered, Hypersensitivity, Interchange of vaccine products
Clinical narrative: Interchange of vaccine products; I am having some issues with those like allergies; Chest pressure; Drug from Sep2022 is a Booster for 2023 and it said that it expired; I realized that it had an expiration date of a whole year ago; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 74-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 27Apr2023 as dose 6 (booster), single (Lot number: GL0087, Expiration Date: Sep2022) at the age of 74 years for covid-19 immunisation. The patient's relevant medical history included: "Blood clots" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "Allergy" (unspecified if ongoing). Concomitant medication(s) included: XARELTO taken for thrombosis; CARDIZEM CD taken for hypertension. Vaccination history included: moderna (DOSE 1, LOT#: 011J20A), administration date: 11Jan2021, when the patient was 72-year-old, for COVID-19 immunization; moderna (DOSE 2, LOT#: 029L20A), administration date: 08Feb2021, when the patient was 72-year-old, for COVID-19 immunization; BNT162b2 (DOSE 3, 1st Pfizer Covid-19 vaccine, LOT#: FF8839), administration date: 15Sep2021, when the patient was 73-year-old, for COVID-19 immunization; BNT162b2 (DOSE 4, 2nd Pfizer Covid-19 vaccine, LOT#: FJ8762), administration date: 19Apr2022, when the patient was 73-year-old, for COVID-19 immunization; BNT162b2 (DOSE 5, 3rd Pfizer Covid-19 vaccine, LOT#: GH9693), administration date: 08Oct2022, when the patient was 74-year-old, for COVID-19 immunization. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious), outcome "unknown"; HYPERSENSITIVITY (non-serious), outcome "unknown", described as "I am having some issues with those like allergies"; CHEST DISCOMFORT (non-serious), outcome "unknown", described as "Chest pressure"; EXPIRED PRODUCT ADMINISTERED (non-serious), outcome "unknown", described as "Drug from Sep2022 is a Booster for 2023 and it said that it expired; I realized that it had an expiration date of a whole year ago". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of hypersensitivity.  Additional information: The patient received Flonase 20 mcg manufacturer unspecified guessed it was made in PRIVACY with Lot H8X, expiry date: Aug 2024. She mentioned that the number said was A142281 and it was Flonase. The first 2 were Moderna, they were all the rest have been Pfizer all 4 have been Pfizer.  The drug from Sep2022 was a Booster for 2023 and it said that it expired; she realized that it had an expiration date of a whole year ago. The patient had some issues with those like allergies or whatever since she took it, but the point was, she wanted to make sure that was actually covered by a Booster that Pfizer as she was suggested to take Booster. She has had little bit of chest pressure but it happened. For investigation the reporter mentioned that "They had just taken blood test to make sure that her A1C was good."